Overview

Structural heart disease refers to a defect in the heart’s valves, walls, or chambers. The most common types of structural heart disease are aortic valve disease, mitral valve disease, tricuspid and pulmonic valve disease, hypertrophic cardiomyopathy and congenital heart disease, such as atrial septal defect and ventricular septal defect.

This New York Transcatheter Valves course is poised to help healthcare professionals stay current on new and emerging approaches in the diagnosis, management and treatment of valvular and structural heart disease. A robust agenda combines individual and collective opinions from field expert clinicians and scholars. The educational format will consist of didactic lectures, live-case transmission of transcatheter procedures, along with moderated discussions and interactive Q&As with our expert faculty.

A Structural Heart Fellows Case Competition will also be featured. Faculty will be looking for outstanding structural heart cases to be presented for the chance to win various prizes.

Learning Objectives

As a comprehensive medical education conference, this symposium will offer the latest updates in diagnostic and treatment strategies that assess the risk and treatment of structural heart disease, such as TAVR, Mitral Valve Repair and Tricuspid Valve Repair. The use of case-based reviews and live case presentations will demonstrate innovative therapeutic techniques. The goal is to provide cardiovas­cular specialists with the education they need in order to improve patient outcomes and reduce morbidity and mortality rates through the management of various conditions.

• Appraise new and upcoming technologies in the management of structural heart disease to determine their benefit for patients.
• Present indications, techniques, outcomes, and complications for transcatheter valve intervention in patients with native valve disease and bioprosthetic valve dysfunction.
• Evaluate the rationale, challenges, and necessity of the heart team approach to valvular heart disease, and appropriate case selection for transcatheter mitral and tricuspid valve intervention.
• Assess the barriers to care in patients with valvular heart disease with specific attention to current gaps in the timely delivery of percutaneous and surgical interventions.

Target Audience

• Interventional Cardiologists
• Invasive Cardiologists
• General Cardiologists who treat patients with Valvular Heart Disease
• Cardiothoracic Surgeons
• Interventional Radiologists
• Interventional Fellows in Training
• Primary Care Providers
• Internists
• Nurses, Technicians and other Allied Health Care
• Professionals who work in Structural Heart Disease

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Gaffney Events. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians. 

The CMEsolutions designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Successful completion of this CME activity, which includes participation in the evaluation component and 75% passing on MOC test, enables the participant to earn up to 7.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Nursing Contact Hour Information: This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation. 7.75 Contact Hours 

ASRT Approved by ASRT 9.5 Category A. 

For more information please visit the official event page.